HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Liposomal daunorubicin (daunosom) in the treatment of recurrent acute promyelocytic leukemia].

AuthorsA V Pivnik, D L Shtroiakovskiĭ, P V Medvedev, T N Moiseeva, N E Shklovskiĭ-Kordi, A A Skorokhod
JournalTerapevticheskii arkhiv (Ter Arkh) Vol. 71 Issue 7 Pg. 24-7 ( 1999) ISSN: 0040-3660 [Print] Russia (Federation)
Vernacular TitleLiposomal'nyĭ daunorubitsin (daunozom) v lechenii retsidiva ostrogo promielotsitarnogo leĭkoza.
PMID10481863 (Publication Type: Case Reports, Comparative Study, Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Liposomes
  • Tretinoin
  • Daunorubicin
Topics
  • Adolescent
  • Adult
  • Antibiotics, Antineoplastic (administration & dosage, pharmacokinetics)
  • Antineoplastic Agents (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Daunorubicin (administration & dosage, pharmacokinetics)
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute (drug therapy)
  • Liposomes
  • Recurrence
  • Time Factors
  • Tretinoin (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: